Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

smith & nephew pty ltd - 43167 - acetabular shell - the sterile outer portion of a two-piece cementless acetabulum prosthesis intended to be used with a liner which serves as an articulating surface. the acetabular shell is inserted into a pre-pared acetabulum with an inserter and impacted into place. it may be further affixed with bone screws. hip components are indicated for individuals undergoing primary and revision surgery where other treatments or devices have failed in rehabilitating hips damaged as a result of degenerative joint disease or any of its composite diagnoses of osteoarthritis, avascular necrosis, and traumatic arthritis. hip components are also indicated for inflammatory degenerative joint disease including rheumatoid arthritis, congenital dysplasia, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques, and fracture-dislocation of the hip.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

link orthopaedics australia pty ltd - 43167 - acetabular shell - the metal casing is made of titanium alloy with a coating of hx(calcium phosphate) and is for cementless fixation. it is pre-drilled with holes for additional screw fixation and includes 2 peep-hole locking screws and 4 screw-hole plugs. it is coupled with a polyethylene insert by snap lock mechanism metal casing acetabular shell component of the top acetabular cup system indicated for use in treatment of mobility-limiting diseases, fractures or defects which cannot be treated by conservative or osteosynthetic procedures ? primary and secondary coxarthrosis ? osteoarthritis ? necrosis of the femoral head ? femoral neck fractures ? revision after implant loosening

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

stryker australia pty ltd - 43167 - acetabular shell - the acetabular shell is seated into the acetabulum as a component of a total hip joint prosthesis, used to replace or repair the acetabulum.the exterior surface of the shell is coated with hydroxyapatite. a component of a total hip joint prosthesis that is used to replace or repair the acetabulum.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

stryker australia pty ltd - 43167 - acetabular shell - the acetabular shell is seated into the acetabulum as a component of a total hip joint prosthesis, used to replace or repair the acetabulum. the exterior surface of the shell is coated with hydroxyapatite. a component of a total hip joint prosthesis that is used to replace or repair the acetabulum.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

zimmer biomet pty ltd - 43167 - acetabular shell - used with an appropriate polyethylene liner to complete the acetabular component. once the metal shell has been secured in the acetabulum, the liner is locked into the shell component. the shells with screw holes permit the use of screws to provide additional fixation and security, particularly where acetabular bone stock is deficient. they are made from tivanium® ti-6al-4v alloy and is coated with calcicoat? hydroxyapatite/tricalcium phosphate (ha/tcp. the trilogy acetabular system is indicated for either cemented or uncemented use in skeletally mature individuals undergoing primary or revision surgery for rehabilitating hips damaged as a result of noninflammatory degenerative joint disease (nidjd) or its composite diagnoses of osteoarthritis, avascular necrosis, protrusio acetabuli, traumatic arthritis, slipped capital epiphysis, fused hip, fracture of the pelvis, and diastrophic variant.

Új-Zéland - angol - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - hydromorphone hydrochloride 16mg (+ 9% overage to account for residual drug retained in capsule shell) - modified release tablet - 16 mg - active: hydromorphone hydrochloride 16mg (+ 9% overage to account for residual drug retained in capsule shell) excipient: butylated hydroxytoluene cellulose acetate hypromellose iron oxide black macrogol 3350 magnesium stearate opacode black ns-78-17821 opadry clear ys-1-19025-a opadry yellow y-30-12863-a polyethylene oxide povidone sodium chloride - jurnista is indicated in the treatment of moderate to severe chronic pain.

Új-Zéland - angol - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - hydromorphone hydrochloride 8mg (+ 9% overage to account for residual drug retained in capsule shell) - modified release tablet - 8 mg - active: hydromorphone hydrochloride 8mg (+ 9% overage to account for residual drug retained in capsule shell) excipient: butylated hydroxytoluene cellulose acetate hypromellose iron oxide black macrogol 3350 magnesium stearate opacode black ns-78-17821 opadry clear ys-1-19025-a opadry red y-30-15595-a polyethylene oxide povidone sodium chloride - jurnista is indicated in the treatment of moderate to severe chronic pain.

Málta - angol - Medicines Authority

rottapharm s.p.a - ispaghula, sennoside b - granules - ispaghula 2.71 gram(s) ; sennoside b 0.015 gram(s)/5 grams - drugs for constipation

Málta - angol - Medicines Authority

ecosse limited “mangion building”, new street off valletta road, luqa, lqa 6000, malta - ispaghula husks - effervescent granules - ispaghula husks 3.5 g - drugs for constipation

Málta - angol - Medicines Authority

neofarma pharmaceuticals limited 42-46, mill street, qormi, qrm 3105, malta - ispaghula husks - effervescent granules - ispaghula husks 3.5 g - drugs for constipation